In addition, we showed that the meningioma/schwannoma-derived NF2 LOF mutations not only compromised its tumor suppressive function in the Hippo pathway, but also gained an oncogenic role for NF2 by activating the VANGL-JNK pathway. The gene discussed is NF2; the disease is schwannoma.